LASHER, TYLER – Trademark Portfolio

Entity Type: 01

LASHER, TYLER holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ELUXX. The owner is based in Tampa, FL.

607 S. Magnolia Avenue

Tampa, FL 33606

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VITALIFY
VITALIFY
Abandoned 2023
VITALIFY
VITALIFY
Abandoned 2023
ELUXX
ELUXX
Abandoned 2023
ELUXX
ELUXX
Registered 2023

Trademark Classifications

LASHER, TYLER's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does LASHER, TYLER have?

LASHER, TYLER has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.

What trademark classes does LASHER, TYLER file in?

LASHER, TYLER files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.

What are LASHER, TYLER's most well-known trademarks?

LASHER, TYLER's registered trademark portfolio includes well-known marks such as ELUXX. These are among 1 currently registered trademark in the portfolio.

What is LASHER, TYLER's trademark registration success rate?

LASHER, TYLER has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.